Skip to contentV
Vycor Medical Inc
V
VYCOVycor Medical Inc Q4 2013 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$301.12K$301.12Kderived+4.9% vs Q4 2012 Net Income-$655.37K-$655.37KderivedN/M vs Q4 2012 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vycor Medical Inc · CIK 1424768 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$247,002−2.2% Operating Incomederived-$588,042N/M Operating Cash Flowderived-$90,565N/M Free Cash Flowderived-$129,806N/M Margins · derivedGross margin82.0%−6.0 pt vs Q4 2012
Operating margin-195.3%−11.0 pt vs Q4 2012
Net margin-217.6%−25.1 pt vs Q4 2012
ended Dec 31, 2013 · filed Apr 7, 2014 · 97 d after period end